Latest filing published 10 Nov 2021 for 仟源医药, €170k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +19.6%Entry CN¥6.29 · Close at T+365 CN¥7.52
- +15.8%Entry CN¥5.68 · Close at T+365 CN¥6.58
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
黄乐群: trading record in brief
All filings by 黄乐群 on record concern 仟源医药, in the capacity of board member. We count 2 filings; the first trade dates from 27 October 2021 and the latest from 10 November 2021.
The open-market record is one-sided, with 2 purchases worth €566k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The latest filing, published on 10 November 2021, reports an open-market purchase of €170k in 仟源医药. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Companies and markets linked to 黄乐群
Open company profiles for insider transactions, fundamentals and analyst consensus when available.